SARS-CoV-2 seroprevalence among healthcare workers in a highly vaccinated Japanese medical center from 2020

SARS-CoV-2 seroprevalence among healthcare workers in a highly vaccinated Japanese medical center from 2020–2023

Published:2024-04-15 Issue:1 Volume:20 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Yan Yan¹,Ito Kanami²,Fukuda Hiroshi¹²,Nojiri Shuko³,Urasaki Wataru⁴⁵,Yamamoto Takamasa⁶,Horiuchi Yuki⁷,Hori Satoshi⁸,Takahashi Kazuhisa⁹,Naito Toshio¹²^ORCID,Tabe Yoko⁶⁷

Affiliation:

1. Department of General Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan

2. Department of Safety and Health Promotion, Juntendo University, Tokyo, Japan

3. Medical Technology Innovation Center, Juntendo University, Tokyo, Japan

4. Clinical Research and Trial Center, Juntendo University, Tokyo, Japan

5. Graduate School of Science and Technology, Tokyo University of Science, Tokyo, Japan

6. Department of Clinical Laboratory, Juntendo University Hospital, Tokyo, Japan

7. Department of Clinical Laboratory Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan

8. Infection Control Science, Juntendo University Graduate School of Medicine, Tokyo, Japan

9. Department of Respiratory Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan

Funder

Japan Agency for Medical Research and Development

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2024.2337984

Reference19 articles.

1. United Nations. WHO chief declares end to COVID-19 as a global health emergency. [accessed 2023 Feb 12]. https://news.un.org/en/story/2023/05/1136367.

2. World Health Organization. COVID-19 epidemiological update – 16 February 2024. [accessed 2024 Feb 12]. https://www.who.int/publications/m/item/covid-19-epidemiological-update-16-february-2024.

3. Testing for COVID-19

4. Ministry of Labour. Health and welfare Japan. Policy changes after COVID-19 becomes a category V infectious disease. [accessed 2023 Aug 19]. [in Japanese]. https://www.mhlw.go.jp/stf/corona5rui.html.

5. National seroepidemiological study of COVID‐19 after the initial rollout of vaccines: Before and at the peak of the Omicron‐dominant period in Japan